Search | BCM

education › ... › lms-troubleshooting-solutions

… please contact the BCM Helpdesk (713) 798-8737) or visit https://bcm.edu/myaccount ) …

education › ... › chapter-leadership

… Jeffrey Hauck Landry Luker Ashley Montgomery Amit Narawane Aaron Pathak … Boulahouache Grace Cardenas (Chair) Yang Ding Jay Jaber Aaron Nguyen Race Schaeffer Promise Ufomadu …

Randomized Phase IIa Clinical Trial Of Cyclosporine For The Treatment Of COVID-19(+) Non-ICU Hospital Inpatients (H-48163)

healthcare › clinical-trials › h-48163

… inpatients will be randomized 2:1 to 7 days of an oral formulation of cyclosporine, Neoral (2.5mg/kg PO BID) … on the World Health Organization (WHO) COVID Ordinal Outcomes Scale, on day 14. Secondary endpoints include safety … a 7-day course of oral cyclosporine (Neoral) on clinical outcome using the World Health Organization (WHO) COVID Ordinal …

Phase I/II Study of Niraparib with Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (H-40404)

healthcare › clinical-trials › h-40404

… The most effective strategy for managing distantly metastatic invasive carcinomas of the … ovarian cancer trials and the concern for toxicities and comorbidities limiting the compliance of concurrent cisplatin for cervical cancer, this … Phase I/II Study of Niraparib with Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix …

Adaptation and Evaluation of SHARE: A Self-Management Intervention for Head and Neck Cancer Patients and their Caregivers (H-38984)

healthcare › clinical-trials › h-38984

… SHARE is a web-based intervention that provides resources for head and neck cancer patients and caregivers to improve … and caregivers who agree to participate will be asked to complete a baseline survey, and will then be given access to … Patients and caregivers will each receive a $10 Clincard for the baseline survey and a $20 Clincard for the follow-up …

MFMU Study: A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix (PROSPECT) (H-53697)

healthcare › clinical-trials › h-53697

… cervical length is known to be an important risk factor for spontaneous preterm birth and to occur more frequently … reduces the risk of prematurity in singleton gestations complicated with a short cervix. This protocol outlines a … MFMU Study: A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix …

A031803: Testing the Addition of Pembrolizumab to Gemcitabine for BCG-Unresponsive Non-muscle Invasive Bladder Cancer (H-50373)

healthcare › clinical-trials › h-50373

… may delay the return of BCG-unresponsive bladder cancer for longer period compared to gemcitabine alone. For more information: … Testing the Addition of Pembrolizumab to Gemcitabine for BCG-Unresponsive Non-muscle Invasive Bladder Cancer …

Graduate School Contacts

education › graduate-school-of-biomedical-sciences › graduate-school-contacts

… of our programs, see full list of graduate programs and visit each of the programs' websites. … regarding the accreditation of Baylor College of Medicine, visit our accreditation website . …

Follow-Up Care After Completion of Initial Treatment

healthcare › ... › follow-up-care-after-treatment

… first five years and then yearly after that. During these visits your physician will be checking for signs that the …

Urinary Incontinence in Women

healthcare › ... › urinary-incontinence-in-women

… and a thorough discussion of your symptoms. During your visit, your urogynecologist may: Ask questions about when … The injections, which are administered during an office visit, typically need to be repeated every six to 12 months. …